Patent assignee · IL · COMPANY

PROCHON BIOTECH LTD.

18Patents
10Active
18Granted
40Portfolio score

Filing activity: Aug 26, 1999 → Feb 23, 2015 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7009039B2 Plasma protein matrices and methods for their preparation Chemistry; Metallurgy 1,383 Expired
US7288406B2 Active variants of FGF with improved specificity Human Necessities 100 Expired
US7276481B2 Method and composition for treatment of skeletal dysplasias Chemistry; Metallurgy 72 Expired
US7563769B2 FGF variants and methods for use thereof Chemistry; Metallurgy 48 Expired
US7335508B2 Porous plasma protein matrices and methods for preparation thereof Chemistry; Metallurgy 29 Expired
US8962556B2 FGF-2 variants having N-terminal deletions and increased receptor selectivity and uses thereof Human Necessities 14 Active
US6265632A Animal model for fibroblast growth factor receptor associated chondrodysplasia Chemistry; Metallurgy 8 Expired
US8193317B2 Freeze-dried fibrin matrices and methods for preparation thereof Chemistry; Metallurgy 7 Active
US8618258B2 Freeze-dried fibrin matrices and methods for preparation thereof Chemistry; Metallurgy 4 Active
US8916522B2 FGF-9 variants and methods of use thereof Chemistry; Metallurgy 4 Active
US7714107B2 Freeze-dried fibrin matrices and methods for preparation thereof Chemistry; Metallurgy 4 Expired
US8119783B2 FGF variants and methods for use thereof Chemistry; Metallurgy 3 Active
US7264946B2 Thermoanaerobacter brockii alcohol dehydrogenase promoter for expression of heterologous proteins Chemistry; Metallurgy 3 Expired
US8940888B2 Hydrazido derivatives of hyaluronic acid Human Necessities 0 Active
US8609823B2 FGF-9 variants and methods for use thereof Chemistry; Metallurgy 0 Active
US9862753B2 FGF-2 variants having N-terminal deletions and increased receptor selectivity and methods of use thereof Human Necessities 0 Active
US9487568B2 FGF-2 variants and methods of use thereof Chemistry; Metallurgy 0 Active
US8524885B2 Hydrazido derivatives of hyaluronic acid Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.